These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2390643

  • 1. Acute lymphoblastic leukemia; factors influencing relapse after allogeneic bone marrow transplantation.
    Zwaan FE, Hermans J.
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():71. PubMed ID: 2390643
    [No Abstract] [Full Text] [Related]

  • 2. Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
    Mrsić M, Nemet D, Labar B, Bogdanić V, Radman I, Zupancić-Salek S, Kovacević-Metelko J, Aurer I, Maravić N.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1268-70. PubMed ID: 8442109
    [No Abstract] [Full Text] [Related]

  • 3. Bone marrow transplantation for acute lymphoblastic leukaemia in first and second remission.
    Barrett AJ, Horowitz MM, McCarthy DM, Kanfer E, Bortin MM.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():247-9. PubMed ID: 2653514
    [No Abstract] [Full Text] [Related]

  • 4. T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma.
    Przepiorka D, Giralt S, Huh YO, Andreeff M, Luna M, Reading C, Thomas M, Champlin RE.
    Transplant Proc; 1992 Dec; 24(6):2906-7. PubMed ID: 1465994
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Aschan J, Ringdén O.
    Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M, Esperou Bourdeau H, Devergie A, Baruchel A, Ribaud P, Socie G, Parquet N, Traineau R, Hirsch I, Schaison G.
    Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S, Naparstek E, Nagler A, Ackerstein A, Kapelushnik J, Or R.
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [Abstract] [Full Text] [Related]

  • 10. Autologous marrow transplantation in acute lymphoblastic leukemia: control of residual disease with mafosfamide and induction of syngeneic GVHD with cyclosporin. The Italian Mafosfamide Study Group.
    Rizzoli V, Carella AM, Carlo-Stella C, Mangoni L.
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():76-8. PubMed ID: 2202474
    [No Abstract] [Full Text] [Related]

  • 11. Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia.
    Barrett AJ.
    Leukemia; 1992 Jul; 6 Suppl 2():139-43. PubMed ID: 1578917
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T, Schattenberg A, Preijers F, Raymakers R, Muus P, Wessels J.
    Bone Marrow Transplant; 1993 Jul; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [Abstract] [Full Text] [Related]

  • 14. [Relapse of acute leukemia after allogeneic bone marrow transplantation].
    Tahara T, Yamazaki T, Abe A, Yamamoto K, Towatari M, Matsuoka A, Matsushita T, Kato H, Toyozumi H, Takeo T.
    Rinsho Ketsueki; 1994 Feb; 35(2):120-6. PubMed ID: 8139109
    [Abstract] [Full Text] [Related]

  • 15. [The effect of HGF on graft-versus-host disease and graft-versus-leukemia after allogeneic bone marrow transplantation in acute lymphoblastic leukemia mice].
    Xia YJ, Gao QP, Wan CC, Cheng FJ, Liu ZX, Guo RC.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):404-7. PubMed ID: 16251021
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C, Aversa F, Raymondi C, Marsella AR, Panizza BM, Perrucci E, Piro F, Maranzano E, Lupattelli M, Martelli MF, Latini P.
    Cancer J Sci Am; 1996 Jul; 2(6):330-4. PubMed ID: 9166553
    [Abstract] [Full Text] [Related]

  • 19. Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemia.
    Lee JH, Choi SJ, Lee JH, Seol M, Lee YS, Ryu SG, Park CJ, Chi HS, Lee MS, Yun S, Lee JS, Lee KH.
    Haematologica; 2005 Oct; 90(10):1380-8. PubMed ID: 16219575
    [Abstract] [Full Text] [Related]

  • 20. The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia.
    Teuffel O, Schrauder A, Sykora KW, Zimmermann M, Reiter A, Welte K, Schrappe M.
    Bone Marrow Transplant; 2005 Jul; 36(2):145-50. PubMed ID: 15908976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.